News
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Interestingly, Wall Street firms largely believe the former will playout in the long run. According to The Wall Street ...
The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.
The string of negative updates from Novo Nordisk and positive news flow from the main competitor Eli Lilly has finally ended ...
When the FDA took Novo Nordisk and Eli Lilly’s GLP-1 medications off of the drug shortage list, the move should have been a ...
Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback